Sera Prognostics (SERA) Revenue & Revenue Breakdown
Sera Prognostics Revenue Highlights
Latest Revenue (Y)
$77.00K
Latest Revenue (Q)
$17.00K
Sera Prognostics Revenue by Period
Sera Prognostics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $77.00K | -74.84% |
| 2023-12-31 | $306.00K | 14.18% |
| 2022-12-31 | $268.00K | 226.83% |
| 2021-12-31 | $82.00K | 228.00% |
| 2020-12-31 | $25.00K | -30.56% |
| 2019-12-31 | $36.00K | - |
Sera Prognostics generated $77.00K in revenue during NA 2024, up -74.84% compared to the previous quarter, and up 213.89% compared to the same period a year ago.
Sera Prognostics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | $17.00K | -55.26% |
| 2025-03-31 | $38.00K | 58.33% |
| 2024-12-31 | $24.00K | -17.24% |
| 2024-09-30 | $29.00K | 20.83% |
| 2024-06-30 | $24.00K | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $41.00K | -2.38% |
| 2023-09-30 | $42.00K | -65.85% |
| 2023-06-30 | $123.00K | 23.00% |
| 2023-03-31 | $100.00K | 53.85% |
| 2022-12-31 | $65.00K | -25.29% |
| 2022-09-30 | $87.00K | 11.54% |
| 2022-06-30 | $78.00K | 105.26% |
| 2022-03-31 | $38.00K | 46.15% |
| 2021-12-31 | $26.00K | 13.04% |
| 2021-09-30 | $23.00K | 15.00% |
| 2021-06-30 | $20.00K | 53.85% |
| 2021-03-31 | $13.00K | 116.67% |
| 2020-12-31 | $6.00K | 20.00% |
| 2020-09-30 | $5.00K | -16.67% |
| 2020-06-30 | $6.00K | -25.00% |
| 2020-03-31 | $8.00K | - |
Sera Prognostics generated $17.00K in revenue during Q2 2025, up -55.26% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Sera Prognostics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| LUCD | Lucid Diagnostics | $4.35B | $1.21B |
| APYX | Apyx Medical | $48.10M | $12.88M |
| RPID | Rapid Micro Biosystems | $28.05M | $7.84M |
| SRZN | Surrozen | $10.65M | $983.00K |
| SERA | Sera Prognostics | $77.00K | $17.00K |
| CGTX | Cognition Therapeutics | - | - |
| STSS | Sharps | - | $83.62K |
| ATOS | Atossa Therapeutics | - | - |
| TVGN | Tevogen Bio | - | - |
| HURA | TuHURA Biosciences | - | - |
| ONCY | Oncolytics Biotech | - | - |